Themis Medicare Ltd

Themis Medicare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Themis Medicare Ltd

₹ 240 5.41%
24 Jul - close price
themismedicare.com BSE: 530199 NSE: THEMISMED
About

Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity.[1]

Key Points

Business Segments[1]
A) Hospital Business - Critical Care Division, Intensive Care Division, Institution Business, Exports. Hospital Business is a major growth driver. Critical Care and Intensive Care teams contribute to building Hospital Business with new launches and increased hospital/doctor’s coverage.

Website BSE NSE
  • Market Cap ₹ 2,212 Cr.
  • Current Price ₹ 240
  • High / Low ₹ 266 / 137
  • Stock P/E 52.5
  • Book Value ₹ 41.0
  • Dividend Yield 0.21 %
  • ROCE 13.5 %
  • ROE 11.8 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Earnings include an other income of Rs.23.6 Cr.
  • Company has high debtors of 170 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
61.77 112.50 107.39 94.92 79.80 94.44 91.00 88.78 80.10 96.65 104.78 82.51 97.82
49.52 72.03 83.93 77.62 65.39 74.07 69.66 73.51 69.62 74.91 92.37 74.46 88.53
Operating Profit 12.25 40.47 23.46 17.30 14.41 20.37 21.34 15.27 10.48 21.74 12.41 8.05 9.29
OPM % 19.83% 35.97% 21.85% 18.23% 18.06% 21.57% 23.45% 17.20% 13.08% 22.49% 11.84% 9.76% 9.50%
2.48 4.82 4.37 4.44 4.25 6.45 6.22 7.13 5.32 6.29 6.66 5.94 4.67
Interest 3.09 2.67 2.05 2.13 1.93 2.26 2.37 2.23 2.71 2.49 2.04 2.68 2.16
Depreciation 2.38 2.35 2.38 2.37 2.39 2.46 2.56 2.67 2.80 3.03 3.07 3.10 3.06
Profit before tax 9.26 40.27 23.40 17.24 14.34 22.10 22.63 17.50 10.29 22.51 13.96 8.21 8.74
Tax % 12.96% 22.52% 17.65% 27.78% 30.61% 21.22% 21.43% 23.94% 18.37% 19.19% 18.91% 10.35% 24.14%
8.05 31.20 19.28 12.46 9.95 17.40 17.78 13.31 8.41 18.19 11.32 7.37 6.64
EPS in Rs 0.88 3.39 2.10 1.35 1.08 1.89 1.93 1.45 0.91 1.98 1.23 0.80 0.72
Raw PDF
Upcoming result date: tomorrow

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
174 195 202 232 217 210 184 202 231 395 354 382
157 171 184 194 184 184 181 166 181 299 287 330
Operating Profit 17 24 18 38 33 25 2 36 49 96 67 52
OPM % 10% 12% 9% 16% 15% 12% 1% 18% 21% 24% 19% 13%
3 5 13 3 4 6 5 12 13 18 25 24
Interest 15 16 15 12 12 12 12 13 13 9 10 9
Depreciation 9 9 11 12 7 7 8 8 9 9 10 12
Profit before tax -4 4 5 17 18 11 -13 27 41 95 73 53
Tax % 56% 32% -20% 11% 9% 1% -15% 8% 14% 23% 22% 19%
-6 3 6 16 16 11 -11 25 36 73 57 44
EPS in Rs -0.79 0.32 0.73 1.91 1.77 1.23 -1.17 2.70 3.88 7.92 6.18 4.73
Dividend Payout % -11% 28% 25% 9% 0% 0% 0% 6% 11% 6% 8% 11%
Compounded Sales Growth
10 Years: 7%
5 Years: 16%
3 Years: 18%
TTM: 8%
Compounded Profit Growth
10 Years: 32%
5 Years: 41%
3 Years: 6%
TTM: -22%
Stock Price CAGR
10 Years: 36%
5 Years: 68%
3 Years: 38%
1 Year: 59%
Return on Equity
10 Years: 14%
5 Years: 18%
3 Years: 18%
Last Year: 12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 8 8 8 9 9 9 9 9 9 9 9 9
Reserves 43 48 51 66 143 160 149 174 209 278 330 368
155 148 140 128 82 80 82 100 87 80 92 96
65 79 77 73 54 56 74 67 65 61 82 93
Total Liabilities 272 284 277 275 289 305 314 350 371 428 514 566
124 121 122 117 124 126 123 116 133 144 162 168
CWIP 11 12 4 6 9 2 2 8 2 3 3 3
Investments 4 4 5 6 23 24 27 35 45 56 70 89
134 147 146 146 133 153 162 191 191 225 279 307
Total Assets 272 284 277 275 289 305 314 350 371 428 514 566

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
4 8 19 26 -2 8 11 0 57 34 16 22
-5 -7 -6 -7 -4 -0 -4 -5 -16 -16 -24 -16
29 2 -18 -13 5 -9 -10 7 -26 -18 0 -9
Net Cash Flow 29 4 -5 5 -0 -1 -3 2 16 1 -8 -3

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 68 74 82 75 81 120 145 186 123 93 149 170
Inventory Days 246 280 246 243 250 253 287 315 272 150 213 188
Days Payable 232 240 237 145 163 156 187 171 143 79 123 126
Cash Conversion Cycle 82 114 91 172 168 216 244 330 251 164 239 232
Working Capital Days 87 81 78 64 74 131 132 176 152 124 176 180
ROCE % 5% 10% 9% 15% 13% 10% -1% 15% 18% 30% 20% 14%

Shareholding Pattern

Numbers in percentages

Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
67.18% 67.18% 67.18% 67.18% 67.17% 67.17% 67.16% 67.16% 67.16% 67.16% 67.15% 67.15%
0.00% 0.00% 0.00% 0.00% 0.02% 0.02% 0.06% 0.04% 0.05% 0.01% 0.03% 0.05%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
32.81% 32.81% 32.81% 32.81% 32.80% 32.78% 32.78% 32.80% 32.77% 32.82% 32.81% 32.79%
No. of Shareholders 6,5116,2125,8915,9156,1266,3625,9276,0076,97011,24411,29511,322

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls